The Effect of Blood Volume Changes on the Glucose Tolerance
NCT ID: NCT02612597
Last Updated: 2015-11-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
20 participants
INTERVENTIONAL
2015-01-31
2016-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators speculate that the concomitant chances in blood volume during training and bedrest might explain the changed insulin sensitivity because with a changing blood volume also the dilution space of the glucose will change.
Furthermore, the investigators would like to work on the influence of a changed capacity of skeletal muscle for glucose uptake and glycogen storage on the glucose sensitivity.
Therefore, A) a bed rest study with healthy untrained subjects and B) a training study with obese pre-diabetic patients will be conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The first hypothesis is that part of the explanation for the known increase in circulating levels of glucose in response to an oral glucose tolerance test (indicating reduced insulin sensitivity) following bed rest is due to a concomitantly reduced blood volume and thereby dilution space.
In addition the investigators also speculate that the reduced glucose response to an oral glucose tolerance test (indicating improved insulin sensitivity) after a training period is related to the exercise induced increase in blood volume, and hence an increased dilution space.
Based on this, the hypothesis to be tested with these two experimental approaches (bed rest and aerobic exercise training), is that at least part of the changes observed in the glucose tolerance following bed rest and aerobic exercise training are related to concomitantly occurring changes in blood volume.
The second hypothesis to be tested is that another important contributor to the changes in circulating glucose levels following an oral glucose tolerance test after bed rest and physical training are related to diminished or improved capacity for skeletal muscle glucose uptake and glycogen storage, respectively. The rationale here fore are that exercise training increases skeletal muscle glycogen content and storage capacity in healthy and type 2 diabetic patients, respectively, and that bed rest does the opposite.
To test this hypothesis two different intervention studies will be conducted. Study 1 is a bed rest study with healthy untrained subjects and study 2 is a training study with obese "pre-diabetic patients".
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Bedrest
4 days of bedrest
Bedrest
Exercise Training
6 weeks of aerobic endurance exercise training with 4 supervised sessions per week at an average intensity of 65 % of maximal heart rate
Exercise Training
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bedrest
Exercise Training
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age: 18-35
* healthy (no chronic diseases)
* BMI: 19-25
* maximal oxygen uptake: 35-50 ml O2/min/kg
* Informed consent as documented by signature
* Age: 35-50
* BMI: 30-40
* Fat%: 30-40 %
* maximal oxygen uptake: 20-35 ml O2/min/kg
* HbA1c: 5.5 - 7.0 %
Exclusion Criteria
* any health problems that do not allow the subjects to participate in the measurements (i.e. heart defect)
* History of familiar history (1st grade relatives) of venous thrombic-embolism or renal insufficiency
* Blood donation in the last month
* Any medication with known influence on blood volume, glucose metabolism and body weight
* Stay above 2500 m for more than 1 day
* Known allergies against Fragmin or Heparin
Training:
* Chronic diseases
* Any health problems that do not allow the subjects to participate in the measurements (i.e. heart defect)
* Blood donation in the last month
* Any medication with known influence on blood volume, glucose metabolism and body weight
* Stay above 2500 m for more than 1 day
18 Years
50 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Carsten Lundby
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Carsten Lundby
Prof. Dr.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Carsten Lundby, Prof. Dr.
Role: PRINCIPAL_INVESTIGATOR
Institute of Physiology, University of Zurich
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institute of Physiology, University of Zurich
Zurich, Canton of Zurich, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KEK-ZH-Nr. 2015-0453
Identifier Type: -
Identifier Source: org_study_id